Por: The Hill Health September 28, 2022
Welcome to Tuesday’s Overnight Health Care, where we’re following the latest moves on policy and news affecting your health. Shutdown watch: the government spending bill appears to be on track to pass later this week, and lawmakers are ready to hit the campaign trail ahead of the mid-term elections. ) and Joseph Choi (). Write to us with tips and feedback, and follow us on Twitter: and Let’s get started. Biden touts Democratic... + full article
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | ABC News
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
ALS drug wins FDA approval despite questionable data | WPLG Local 10
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
PennLive USA Nation September 30, 2022
WASHINGTON — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
CNBC USA Health September 29, 2022
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.The drug, from the Massachusetts-based , joins... + más
Newsweek USA Nation September 29, 2022
President Joe Biden warned oil companies that his administration will take action if they use Hurricane Ian as excuse to raise prices at the pump. However, it's not yet clear what Biden's plans are for cracking down on potential price gouging.Biden, speaking at the... + más
Hurricane Ian Live Updates: Florida watching for price gouging | Orlando Sentinel
Hurricane Ian evacuee upset over price hike at Jupiter hotel | WPTV
10 WBNS USA Health September 17, 2022
WASHINGTON — When Emmanuel Obeng-Dankwa is worried about making rent on his New York City apartment, he sometimes holds off on filling his blood pressure medication. “If there’s no money, I prefer to skip the medication to being homeless,” said Obeng-Dankwa, a... + más
Power Poll finds broad support to recall LaToya Cantrell, much doubt it will happen | The Advocate
New poll: Gov. DeWine holds strong lead, Rep. Tim Ryan a narrow one | 10 WBNS
About iurex | Privacy Policy | Disclaimer |